Cardiac failure in diabetics: Taubman Institute brings leading expert to Ann Arbor March 15
Visiting Professor lecture series continues with Dr. E. Dale Abel
Dr. E. Dale Abel of the University of Utah School of Medicine will present two talks on the U-M campus on March 15, hosted by the Taubman Institute's Visiting Professor program and other U-M medical school departments.
Dr. Abel will speak about "Insulin Signaling and Cardiovascular Disease" at noon at the U-M Health System's Ford Auditorium as part of a grand rounds series.
At 2 p.m. he will presents "Molecular Insights into Diabetic Cardiomyopathy" in Room 5050 of the U-M Brehm Tower at 1000 Wall Street in Ann Arbor. This lecture is presented by the Endocrinology Research Seminar.
Dr. Abel, a professor of medicine, biochemistry and human genetics, also is the chief of the division of endocrinology, metabolism and diabetes at the University of Utah School of Medicine; the H.A. and Edna Benning Presidential Endowed Chair in Diabetes and Endocrinology and a senior investigator in the university's Program in Molecular Medicine.
The events are open to the public; no registration is required. CME credit is offered.
Help Us Make A Difference. Make A Donation That Could Save Lives.
Taubman Science
ALS patient feels great after stem cell transplant
Took part in Phase I of Dr. Eva Feldman's human clinical trial
Ted Harada tells Crain's Detroit Business that nearly nine months after receiving stem cell injections to his spinal cord, improvement persists.
Click here to read the interview
Clinical Trials
The birth of two human clinical trials
The Taubman Institute’s overriding purpose is to discover potential new treatments that can be tested in clinical trials. Watch as two Taubman Scholars explain how they made it happen.
Taubman Science
Institute training video helps physicians overseas
U-M exam method for diabetic nerve damage translated to Mandarin Chinese. The Taubman Institute has produced video of an exam protocol that will help doctors in Asia and elsewhere as they grapple with growing diabetes epidemics and the resulting complications.
news & events
The Latest
-
Dr. Eva Feldman discusses stem cell therapies on Michigan Radio
June 14, 2013 -
2013 Taubman Prize
June 05, 2013 -
Stem cell treatment "dramatically slows ALS" in some patients
May 31, 2013
Taubman Science
Taubman Scholars direct 31 human clinical trials
Science funded by the Taubman Institute has led to 31 current human clinical trials, studying potential therapies for diseases including breast cancer, muscular dystrophy, diabetes and ALS. See the complete list of trials.
People who care
Generous donors fund institute's summer students
Leadership advisory board members fund Tauber Family Student Internship Program
Three future medical scientists will work with Taubman Institute researchers starting in June.
Accomplishments
State leaders laud Taubman Institute accomplishments
Leaders of state and local government visited the Taubman Institute on March 18 to tour Taubman Scholar labs and discuss the potential medical research offers for both improving the health of residents and establishing new jobs and businesses in Michigan.
Donors pitch in to keep brilliant science minds at U-M Video
